Overview
Peter Barth is a Hematologist Oncology provider in Providence, Rhode Island. Dr. Barth is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Essential Thrombocythemia, and Childhood Iron Deficiency Anemia.
His clinical research consists of co-authoring 17 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Thrombocytopenia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Camille Bedrosian is a Hematologist Oncology provider in Cambridge, Massachusetts. Dr. Bedrosian is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, and Atypical Hemolytic Uremic Syndrome (aHUS).
Massachusetts General Physicians Organization Inc
Pavan Bendapudi is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Bendapudi is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Purpura, Thrombocytopenia, Blood Clots, and Disseminated Intravascular Coagulation. Dr. Bendapudi is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Nathan Connell is a Hematologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Connell is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Von Willebrand Disease (VWD), Thrombocytopenia, Sickle Cell Disease, and Blood Clots. Dr. Connell is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Essential ThrombocythemiaDr. Barth isDistinguished. Learn about Essential Thrombocythemia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Barth isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Autoimmune Hemolytic AnemiaDr. Barth isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Childhood Iron Deficiency Anemia
- Chronic B-Cell Leukemia (CBCL)Dr. Barth isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Follicular LymphomaDr. Barth isAdvanced. Learn about Follicular Lymphoma.
- Hemangioma Thrombocytopenia Syndrome
- Experienced
- Acute Eosinophilic PneumoniaDr. Barth isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Barth isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Barth isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Barth isExperienced. Learn about Agranulocytosis.